- Product Portfolio
- Market Information
- Poultry Meat
- Poultry Future
- Events & Resources
- Industry Resources
- Support & Services
- Stay Connected
Watch on-demand now to learn the latest updates on Mycoplasma gallisepticum.
Mycoplasma gallisepticum (MG) is a major health, welfare and economic challenge for commercial egg layer operations because biosecurity and prevention programs often fail. The current consensus is that existing prevention tools need to work together within a strategic framework to improve MG control. In this webinar, our guest speaker, Dr. Naola Ferguson, shares the findings from a recent study exploring the benefits of a new MG prevention protocol combining live and inactivated MG vaccines to reduce mycoplasma replication and achieve stronger protection.
WHAT YOU’LL LEARN:
This webinar is sponsored by Elanco and is presented by WATTPoultry and WATT Global Media.
Dr. Naola M. Ferguson-Noel, DVM, MAM, PHD, associate professor at Poultry Diagnostic & Research Center Department of Population Health, University of Georgia
Dr. Ferguson is currently an associate professor at the Poultry Diagnostic and Research Center (PDRC) at the University of Georgia. She received her DVM at the University of the West Indies followed by her Masters of Avian Medicine and PhD in Medical Microbiology at the University of Georgia, College of Veterinary Medicine. Dr. Ferguson’s research focus is avian mycoplasma diagnostics, epidemiology, pathogenicity and vaccination. In addition to research, Dr. Ferguson oversees the avian mycoplasma and molecular bacteriology diagnostic service at PDRC; she also regularly conducts workshops and continuing education seminars.